These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4906138)

  • 1. Nicotinic acid in the prevention and treatment of methionine-induced exacerbation of psychopathology in schizophrenics.
    Ananth JV; Ban TA; Lehmann HE; Bennett J
    Can Psychiatr Assoc J; 1970 Feb; 15(1):15-20. PubMed ID: 4906138
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics.
    Ananth JV; Ban TA; Lehmann HE
    Can Psychiatr Assoc J; 1973 Oct; 18(5):377-83. PubMed ID: 4147710
    [No Abstract]   [Full Text] [Related]  

  • 3. Nicotinic acid and catechol-O-methyl-transferase activity in schizophrenia.
    Ban TA; Lehmann HE; Klingner A
    Int J Clin Pharmacol; 1973 Feb; 7(1):44-7. PubMed ID: 4699383
    [No Abstract]   [Full Text] [Related]  

  • 4. Nicotinic acid and nicotinamide in the treatment of chronic schizophrenia.
    Vallely JF; Lovegrove TD; Hobbs GE
    Can Psychiatr Assoc J; 1971 Oct; 16(5):433-5. PubMed ID: 4261335
    [No Abstract]   [Full Text] [Related]  

  • 5. Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study.
    Ananth JV; Vacaflor L; Kekhwa G; Sterlin C; Ban TA
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):406-10. PubMed ID: 4261601
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Megavitamin treatment in schizophrenia.
    Hoffer J
    Can Psychiatr Assoc J; 1976 Mar; 21(2):133-4. PubMed ID: 776387
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicotinic acid in the treatment of schizophrenias. Canadian Mental Health Association collaborative study: progress report II.
    Ban TA; Lehmann HE
    Can Psychiatr Assoc J; 1975 Mar; 20(2):103-12. PubMed ID: 1100217
    [No Abstract]   [Full Text] [Related]  

  • 8. Nicotinic acid in the treatment of chronic hospitalized schizophrenic patients: a placebo-controlled clinical study.
    Deutsch M; Ananth JV; Ban TA
    Psychopharmacol Bull; 1977 Jul; 13(3):21-3. PubMed ID: 142260
    [No Abstract]   [Full Text] [Related]  

  • 9. A controlled study of lithium vs. chlorpromazine in acute schizophrenics.
    Shopsin B; Kim SS; Gershon S
    Br J Psychiatry; 1971 Oct; 119(551):435-40. PubMed ID: 4942959
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenothiazine-induced decompensation.
    Van Putten T; Mutalipassi LR; Malkin MD
    Arch Gen Psychiatry; 1974 Jan; 30(1):102-5. PubMed ID: 4587065
    [No Abstract]   [Full Text] [Related]  

  • 11. Two pilot studies of AHR-1680 in chronic schizophrenic patients.
    Sugerman AA; Herrmann J; O'Hara M; Simpson GM; Angus JW; Deutsch L
    J Clin Pharmacol J New Drugs; 1969; 9(3):183-6. PubMed ID: 4892454
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of nicotinic acid and pyridoxine in the treatment of schizophrenia.
    Petrie WM; Ban TA; Ananth JV
    Int Pharmacopsychiatry; 1981; 16(4):245-50. PubMed ID: 7040274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic acid in the treatment of schizophrenia.
    Med Lett Drugs Ther; 1973 Dec; 15(26):107-8. PubMed ID: 4271841
    [No Abstract]   [Full Text] [Related]  

  • 14. Nicotinic acid and nicotinamide adenine dinucleotide (NAD) therapy in schizophrenia: a review.
    Wittkopp TA; Abuzzahab FS
    Behav Neuropsychiatry; 1972; 4(7-8):6-12. PubMed ID: 4348727
    [No Abstract]   [Full Text] [Related]  

  • 15. Transmethylation hypothesis of schizophrenia: methionine and nicotinic acid.
    Nestoros JN; Ban TA; Lehmann HE
    Int Pharmacopsychiatry; 1977; 12(4):215-46. PubMed ID: 338534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic acid therapy in chronic schizophrenia.
    Sehdev HS; Olson JL
    Compr Psychiatry; 1974; 15(6):511-7. PubMed ID: 4609684
    [No Abstract]   [Full Text] [Related]  

  • 17. A search for responders to niacin supplementation.
    Wittenborn JR
    Arch Gen Psychiatry; 1974 Oct; 31(4):547-52. PubMed ID: 4607587
    [No Abstract]   [Full Text] [Related]  

  • 18. Niacin in the long-term treatment of schizophrenia.
    Wittenborn JR; Weber ES; Brown M
    Arch Gen Psychiatry; 1973 Mar; 28(3):308-15. PubMed ID: 4569673
    [No Abstract]   [Full Text] [Related]  

  • 19. Negative findings with nicotinic acid in the treatment of schizophrenias.
    Ban TA
    Int Pharmacopsychiatry; 1974; 9(3):172-87. PubMed ID: 4430570
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of resistant schizophrenics with extreme high dosage fluphenazine hydrochloride.
    Itil T; Keskiner A; Heinemann L; Han T; Gannon P; Hsu W
    Psychosomatics; 1970; 11(5):456-63. PubMed ID: 4919176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.